Alzheimer's disease : optimizing drug development strategies in the news

Biogen, Eisai to shift some Alzheimer's drug production to US

Read on: Nikkei

Alzheimer's-related dementia could be prevented by experimental drug, researchers say

Read on: Fox News

Experimental drug may slow dementia onset for patients with rare genetic form of Alzheimer's

Read on: Euronews

New drug could reduce risk of early-onset Alzheimer's disease

Read on: Independent

Two patients navigate the new Alzheimer's drugs

Read on: NPR

Alzheimer's wonder drugs may shrink your brain - should we be worried?

Read on: Express

Swedish patients could face long wait for new early Alzheimer's drug

Read on: Sverige Radio

What Drugmakers Did Not Tell Volunteers in Alzheimer's Trials

Read on: The New York Times

Alzheimer's drug may someday help save lives by inducing a state of 'suspended animation'

Read on: Phys

The truth about the new class of Alzheimer's drugs

Read on: New Scientist

Game-changing Alzheimer's drug

Read on: EuroWeeklyNews

A drug to slow Alzheimer's is finally available. How are patients faring?

Read on: NZ Herald

For Beaten-Down Maker of Alzheimer's Drug, Good Enough Will Do

Read on: The Wall Street Journal

For Beaten-Down Maker of Alzheimer's Drug, Good Enough Will Do

Read on: The Wall Street Journal

Alzheimer's drug embrace slows down as US doctors' reluctance grows

Read on: Fox News

It's the first drug shown to slow Alzheimer's. Why is it off to a slow start?

Read on: The Washington Times

Alzheimer's drug fermented with help from AI and bacteria moves closer to reality

Read on: Phys

F.D.A. Delays Action on Closely Watched Alzheimer's Drug

Read on: The New York Times

Controversial Alzheimer's drug exits the stage

Read on: Axios